Panacea Biotec
BSE: 531349 | NSE: PANACEABIO | ISIN: INE922B01023 | Pharmaceuticals
 |
Balance Sheet of Panacea Biotec |
------------------- in Rs. Cr. ------------------- |
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Sources Of Funds | ||||||||||
| Total Share Capital | 96.15 | 96.15 | 6.58 | 6.68 | 6.68 | |||||
| Equity Share Capital | 5.72 | 5.72 | 6.58 | 6.68 | 6.68 | |||||
| Share Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preference Share Capital | 90.43 | 90.43 | 0.00 | 0.00 | 0.00 | |||||
| Reserves | 119.24 | 154.60 | 532.51 | 690.53 | 598.87 | |||||
| Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Networth | 215.39 | 250.75 | 539.09 | 697.21 | 605.55 | |||||
| Secured Loans | 134.25 | 115.85 | 0.06 | 207.04 | 483.59 | |||||
| Unsecured Loans | 26.79 | 470.81 | 213.36 | 191.21 | 216.70 | |||||
| Total Debt | 161.04 | 586.66 | 213.42 | 398.25 | 700.29 | |||||
| Total Liabilities | 376.43 | 837.41 | 752.51 | 1,095.46 | 1,305.84 | |||||
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Application Of Funds | ||||||||||
| Gross Block | 162.77 | 208.08 | 382.66 | 465.81 | 741.12 | |||||
| Less: Accum. Depreciation | 53.62 | 71.07 | 105.33 | 147.60 | 217.01 | |||||
| Net Block | 109.15 | 137.01 | 277.33 | 318.21 | 524.11 | |||||
| Capital Work in Progress | 28.54 | 96.70 | 123.72 | 216.16 | 169.76 | |||||
| Investments | 6.14 | 6.14 | 22.95 | 204.93 | 216.57 | |||||
| Inventories | 191.01 | 180.45 | 208.16 | 211.64 | 447.80 | |||||
| Sundry Debtors | 78.73 | 77.45 | 92.92 | 148.26 | 123.88 | |||||
| Cash and Bank Balance | 5.48 | 24.35 | 99.53 | 16.08 | 52.43 | |||||
| Total Current Assets | 275.22 | 282.25 | 400.61 | 375.98 | 624.11 | |||||
| Loans and Advances | 51.35 | 79.93 | 158.47 | 47.62 | 184.20 | |||||
| Fixed Deposits | 2.02 | 417.10 | 57.59 | 125.10 | 7.05 | |||||
| Total CA, Loans & Advances | 328.59 | 779.28 | 616.67 | 548.70 | 815.36 | |||||
| Deffered Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Current Liabilities | 73.22 | 131.95 | 186.35 | 175.57 | 234.57 | |||||
| Provisions | 24.21 | 50.75 | 102.51 | 17.53 | 185.75 | |||||
| Total CL & Provisions | 97.43 | 182.70 | 288.86 | 193.10 | 420.32 | |||||
| Net Current Assets | 231.16 | 596.58 | 327.81 | 355.60 | 395.04 | |||||
| Miscellaneous Expenses | 1.45 | 0.96 | 0.70 | 0.53 | 0.37 | |||||
| Total Assets | 376.44 | 837.39 | 752.51 | 1,095.43 | 1,305.85 | |||||
|
||||||||||
| Contingent Liabilities | 18.55 | 92.42 | 14.20 | 41.51 | 48.55 | |||||
| Book Value (Rs) | 21.89 | 28.09 | 82.08 | 104.54 | 90.80 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Panacea Biotec connections | ||||||||||
| ||||||||||
